IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis. F. HARUNA, A. LIPSETT, L. MARIGNOL (Dublin, Ireland). Anticancer Res 37: 5343-5353, 2017.
Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update. D. GLASSMAN, S. HIGNETT, S. REHMAN, R. LINFORTH, M. SALHAB (Bradford, UK). Anticancer Res 37: 5329-5341, 2017.
Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma. A. NÄSMAN, C. BERSANI, D. LINDQUIST, J. DU, T. RAMQVIST, T. DALIANIS (Stockholm; Umeå, Sweden). Anticancer Res 37: 5319-5328, 2017.
Anticancer Activity of Artemisinin and its Derivatives. S. SLEZAKOVA, J. RUDA-KUCEROVA (Brno, Czech Republic). Anticancer Res 37:5995-6003, 2017.
Possible Biological and Clinical Applications of Phenothiazines. B. VARGA, Á. CSONKA, A. CSONKA, J. MOLNÁR, L. AMARAL, G. SPENGLER (Szeged, Hungary; Lisbon, Portugal). Anticancer Res 37:5983-5993, 2017.
Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment. B.N. HO, C.M. PFEFFER, A.T.K. SINGH (Kenosha, WI, USA). Anticancer Res 37:5975-5981, 2017.
Perioperative Administration of Traditional Japanese Herbal Medicine Daikenchuto Relieves Postoperative Ileus in Patients Undergoing Surgery for Gastrointestinal Cancer: A Systematic Review and Meta-analysis. M. ISHIZUKA, N. SHIBUYA, H. NAGATA, K. TAKAGI, Y. IWASAKI, H. HACHIYA, T. AOKI, K. KUBOTA (Tochigi, Japan). Anticancer Res 37:5967-5974, 2017.
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research. A. GADDUCCI, M.E. GUERRIERI (Pisa, Italy). Anticancer Res 37:5955-5965, 2017.
New Drug Combination Strategies in Melanoma: Current Status and Future Directions. A. NAJEM, M. KRAYEM, A. PERDRIX, J. KERGER, A. AWADA, F. JOURNE, G. GHANEM (Brussels; Mons, Belgium; Rouen, France). Anticancer Res 37:5941-5953, 20
Monoclonal Antibodies for the Treatment of Cancer. J.T. PENTO (Oklahoma, OK, USA). Anticancer Res 37:5935-5939, 2017.
A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer. J. MERCIER, I.A. VOUTSADAKIS (Sudbury; Sault Ste Marie, ON, Canada). Anticancer Res 37:5925-5934, 2017.
Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity. Y. SUGITA, K. TAKAO, Y. UESAWA, H. SAKAGAMI (Sakado; Tokyo, Japan). Anticancer Res 37:5919-5924, 2017.
Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System. M. BERGER, D. VON SCHWEINITZ (Munich, Germany). Anticancer Res 37:5911-5918, 2017.
Fluoride Induces Apoptosis in Mammalian Cells: In Vitro and In Vivo Studies. D.A. RIBEIRO, C.M. CARDOSO, V.Q. YUJRA, M.D.B. VIANA, O. AGUIAR JR, L.P. PISANI, C.T.F. OSHIMA (Sao Paulo, Brazil). Anticancer Res 37:4767-4778, 2017.
Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants. F. CARINI, M. MAZZOLA, F. RAPPA, A. JURJUS, A.G. GEAGEA, S. AL KATTAR, T. BOU-ASSI, R. JURJUS, P. DAMIANI, A. LEONE, G. TOMASELLO (Palermo, Italy; Beirut; Jal El Dib, Lebanon; Washington, DC, USA). Anticancer Res 37:4759-4766, 2017.
Deepening a Simple Question: Can MSCs Be Used to Treat Cancer? J.P.A. GOMES, A.F. ASSONI, M. PELATTI, G. COATTI, O.K. OKAMOTO, M. ZATZ (Sao Paulo, Brazil). Anticancer Res 37:4747-4758, 2017.
Physical Needs of Long-term Cancer Patients. P. TRALONGO, M.G. PESCARENICO, A. SURBONE, S. BORDONARO, M. BERRETTA, A. DI MARI (Syracuse; Parma; Aviano, Italy; New York, NY, USA). Anticancer Res 37:4733-4746, 2017.
Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. J.P. CATA, M.F. RAMIREZ, J.F. VELASQUEZ, A. DI, K.U. POPAT, V. GOTTUMUKKALA, D.M. BLACK, V.O. LEWIS, J.N. VAUTHEY (Houston; Temple, TX; Boston, MA, U.S.A.; Medellin, Colombia). Anticancer Res 37:4727-4732, 2017.
Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies. D. GU, A. SZALLASI (Livingston, NJ; Jacksonville, FL, USA). Anticancer Res 37:4717-4726, 2017.
Impact of Parental Cancer on Children. B.K. SHAH, J. ARMALY, E. SWIETER (Sedro-Woolley; Yakima, WA, USA). Anticancer Res 37:4025-4028, 2017.
Genotoxicity Induced by Dental Materials: A Comprehensive Review. D.A. RIBEIRO, V.Q. YUJRA, C.F.G. DE MOURA, B.A. HANDAN, M.D.B. VIANA, L.Y. YAMAUCHI, P.M. CASTELO, O. AGUIAR JR (Sao Paolo, Brazil). Anticancer Res 37:4017-4024, 2017.
Lower Body Lymphedema in Patients with Gynecologic Cancer. N. BIGLIA, V. ZANFAGNIN, A. DANIELE, E. ROBBA, V.E. BOUNOUS (Turin, Italy). Anticancer Res 37:4005-4016, 2017.
Vitamin D Receptor Polymorphism and Cancer: An Update. V. RAI, J. ABDO, S. AGRAWAL, D.K. AGRAWAL (Omaha, NE, USA). Anticancer Res 37:3991-4004, 2017.
BDNF: An Oncogene or Tumor Suppressor? D.P. RADIN, P. PATEL (Stony Brook; New York City, NY, USA). Anticancer Res 37:3983-3990, 2017.
Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma. K. TAJIRI, T. SUDOU, F. FUJITA, T. HISAKA, T. KINUGASA, Y. AKAGI (Fukuoka, Japan). Anticancer Res 37:3817-3824, 2017.
Clinical Implications of Augmenter of Liver Regeneration in Cancer: A Systematic Review. K.H. NGUYEN, A.H. NGUYEN, D.V. DABIR (Los Angeles, CA, USA). Anticancer Res 37:3379-3384, 2017.
Application of Cancer Cell Reprogramming Technology to Human Cancer Research.  X.-Y. PAN, M.-H. TSAI, K. WUPUTRA, C.-C. KU, W.-H. LIN, Y.-C. LIN, S. KISHIKAWA, M. NOGUCHI, S. SAITO, C.-S. LIN, K.K. YOKOYAMA (Hanzhou, PR China; Kaohsiung, Taiwan, ROC; Tsukuba; Yaita; Tokyo; Sanuki, Japan). Anticancer Res 37:3367-3378, 2017.
Desmoid Tumors in Familial Adenomatous Polyposis. M.L. DE MARCHIS, F. TONELLI, D. QUARESMINI, D. LOVERO, D. DELLA-MORTE, F. SILVESTRIS, F. GUADAGNI, R. PALMIROTTA (Rome; Florence; Bari, Italy). Anticancer Res 37:3357-3366, 2017.
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability. E. VIRGILIO, A. PROIETTI, R. D’URSO, P. CARDELLI, E. GIARNIERI, M. MONTAGNINI, M.R. GIOVAGNOLI, P. MERCANTINI, G. BALDUCCI, M. CAVALLINI (Rome, Italy). Anticancer Res 37:2817-2822,2017.
Targeted Therapy in Ovarian Cancer. A Comprehensive Systematic Review of Literature. Y. DIAB, M.Z. MUALLEM (Victoria, Australia; Berlin, Germany). Anticancer Res 37:2809-2816,2017.
Cancer Tissue Classification, Associated Therapeutic Implications and PDT as an Alternative. T.K. HORNE, M.J. CRONJE (Johannesburg, South Africa). Anticancer Res 37:2785-2808,2017.
Erdheim–Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances. F. HAROUN, K. MILLADO, I. TABBARA (Washington, DC, USA). Anticancer Res 37:2777-2784,2017.
Pancreatic Cancer Stem Cells and Therapeutic Approaches. G. ERCAN, A. KARLITEPE, B. OZPOLAT (Izmir, Turkey; Houston, TX, USA). Anticancer Res 37:2761-2776,2017.
68Ga-PSMA-PET/CT Ηas a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease. C. FITZPATRICK, O. LYNCH, L. MARIGNOL (Dublin, Ireland). Anticancer Res 37:2753-2760,2017.
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas. D. MORIS, C. DAMASKOS, E. SPARTALIS, A. PAPALAMPROS, S. VERNADAKIS, D. DIMITROULIS, J. GRINIATSOS, E. FELEKOURAS, N. NIKITEAS (Columbus, OH, USA; Athens, Greece; Riyadh, Kingdom of Saudi Arabia). Anticancer Res 37:2185-2194,2017.
Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer. A.D.C. PAULA, C. LOPES (Porto, Portugal). Anticancer Res 37:2173-2183,2017.
The Kynurenine Pathway: A Primary Resistance Mechanism in Patients with Glioblastoma. P.P. SORDILLO, L.A. SORDILLO, L. HELSON (Quakertown, PA; New York, NY, USA). Anticancer Res 37:2159-2171,2017.
Antitumor and Cancer-preventative Function of Fucoxanthin: A Marine Carotenoid. Y. SATOMI (Suzuka, Japan). Anticancer Res 37:1557-1562, 2017.
Acute Graft Versus Host Disease: A Comprehensive Review. S. NASSEREDDINE, H. RAFEI, E. ELBAHESH, I. TABBARA (Washington, DC; Huntsville, AL, USA). Anticancer Res 37:1547-1555, 2017.
Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature. A. DOGAN, B. SCHULTHEIS, G.A. REZNICZEK, Z. HILAL, C. CETIN, G. HÄUSLER, C.B. TEMPFER (Bochum, Germany; Mauerbach, Austria). Anticancer Res 37:969-978, 2017.
The role of IL-7 in Immunity and Cancer. J. LIN, Z. ZHU, H. XIAO, M.R. WAKEFIELD, V.A. DING, Q. BAI, Y. FANG (Des Moines, IA; Columbia, MO, USA; Chenzhou, PR China). Anticancer Res 37:963-967, 2017.
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. I. MARINELLI, A. GUIDO, L. FUCCIO, A. FARIOLI, V. PANNI, L. GIACCHERINI, A. ARCELLI, G. ERCOLANI, G. BRANDI, S. CAMMELLI, A. GALUPPI, G. MACCHIA, R. FRAKULLI, G.C. MATTIUCCI, F. CELLINI, M. BUWENGE, M. RENZULLI, F. DEODATO, S. CILLA, V. VALENTINI, V. TOMBOLINI, R. GOLFIERI, A.G. MORGANTI (Rome; Bologna; Campobasso, Italy). Anticancer Res 37:955-961, 2017.
Possible Therapeutic Effects of Ozone Mixture on Hypoxia in Tumor Development. M. LUONGO, A.L. BRIGIDA, L. MASCOLO, G. GAUDINO (Naples, Italy). Anticancer Res 37:425-435, 2017.
Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights. A. FANDELLA, V. SCATTONI, A. GALOSI, P. PEPE, M. FIORENTINO, C. GAUDIANO, M. GIAMPAOLI, R. GUNELLI, P. MARTINO, V. MONTANARO, R. MONTIRONI, T. PIERANGELI, A. STABILE, A. BERTACCINI (Treviso; Milan; Ancona; Catania; Bologna; Forlì; Bari; Naples, Italy). Anticancer Res 37:413-424, 2017.
Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer. D. VRANA, M. MATZENAUER, R. AUJESKY, R. VRBA, C. NEORAL, B. MELICHAR, P. SOUČEK (Olomouc; Prague, Czech Republic). Anticancer Res 37:403-412, 2017.
The Evolving Role of Local Treatments for HCC in the Third Millennium. P. MAGISTRI, G. TARANTINO, R. BALLARIN, M. BERRETTA, Α. PECCHI, G. RAMACCIATO, F. DI BENEDETTO (Modena; Rome; Aviano, Italy). Anticancer Res 37:389-401, 2017.
Immune-based Therapies for Non-small Cell Lung Cancer. H. RAFEI, E. EL-BAHESH, A. FINIANOS, S. NASSEREDDINE, I. TABBARA (Washington, DC; Huntsville, AL, USA; Jounieh, Lebanon). Anticancer Res 37:377-387, 2017.
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer. C. DAMASKOS, S. VALSAMI, M. KONTOS, E. SPARTALIS, T. KALAMPOKAS, E. KALAMPOKAS, A. ATHANASIOU, D. MORIS, A. DASKALOPOULOU, S. DAVAKIS, G. TSOUROUFLIS, K. KONTZOGLOU, D. PERREA, N. NIKITEAS, D. DIMITROULIS (Athens, Greece; Aberdeen, UK; Cleveland, OH, USA). Anticancer Res 37:35-46, 2017.
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. J. POLIVKA JR, J. POLIVKA, L. HOLUBEC, T. KUBIKOVA, V. PRIBAN, O. HES, K.  PIVOVARCIKOVA, I. TRESKOVA (Plzen, Czech Republic).  Anticancer Res 37:21-34, 2017.
Three Pathways of Colonic Carcinogenesis in Rats. C.A. RUBIO (Stockholm, Sweden).  Anticancer Res 37:15-20, 2017.
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system